Literature DB >> 6776014

Intestinal absorption in lysinuric protein intolerance: impaired for diamino acids, normal for citrulline.

J Rajantie, O Simell, J Perheentupa.   

Abstract

Lysinuric protein intolerance (LPI) is an autosomal recessive defect of diamino acid transport characterised by massive diaminoaciduria, especially lysinuria, with hyperammonaemia after heavy nitrogen intake. The defect has previously been demonstrated in the kidney, and is probably present in the liver cells. To evaluate the effect of the LPI gene on the net intestinal absorption of the diamino acids and citrulline, separate oral loads of each were given to controls, and to subjects heterozygous and homozygous for LPI. In the affected subjects the plasma concentrations of the loaded diamino acids showed lower increments after the loads than in the controls, the difference being marked in the homozygotes and moderate in the heterozygotes. Urinary excretion failed to explain these differences. Thus, the diamino acid transport defect of LPI is also present in the intestine. After citrulline loads, in contrast, plasma citrulline levels rose similarly in controls and homozygotes. Thus, LPI is associated with intact citrulline absorption. The ornithinopenic hyperammonaemia of LPI is probably preventable by supplementing dietary protein with the ornithine precursor citrulline.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776014      PMCID: PMC1419667          DOI: 10.1136/gut.21.6.519

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  Dibasic amino acid absorption in man.

Authors:  M D Hellier; C D Holdsworth; D Perrett
Journal:  Gastroenterology       Date:  1973-10       Impact factor: 22.682

2.  Defective metabolic clearance of plasma arginine and ornithine in lysinuric protein intolerance.

Authors:  O Simell; J Perheentupa
Journal:  Metabolism       Date:  1974-08       Impact factor: 8.694

3.  Hyperlysinuria with hyperammonemia. A new metabolic disorder.

Authors:  J H Brown; L F Fabre; G L Farrell; E D Adams
Journal:  Am J Dis Child       Date:  1972-07

4.  Intestinal absorption of L-arginine and L-lysine in familial protein intolerance.

Authors:  M Kekomäki
Journal:  Ann Paediatr Fenn       Date:  1968

5.  Congenital lysinuria: a new inherited transport disorder of dibasic amino acids.

Authors:  K Oyanagi; R Miura; T Yamanouchi
Journal:  J Pediatr       Date:  1970-08       Impact factor: 4.406

6.  Hyperdibasicaminoaciduria: an inherited disorder of amino acid transport.

Authors:  D T Whelan; C R Scriver
Journal:  Pediatr Res       Date:  1968-11       Impact factor: 3.756

7.  Hyperdibasicaminoaciduria in a mentally retarded homozygote with a peculiar response to phenothiazines.

Authors:  H Kihara; M Valente; M T Porter; A L Fluharty
Journal:  Pediatrics       Date:  1973-02       Impact factor: 7.124

8.  Protein intolerance with deficient transport of basic aminoacids. Another inborn error of metabolism.

Authors:  J Perheentupa; J K Visakorpi
Journal:  Lancet       Date:  1965-10-23       Impact factor: 79.321

9.  Familial protein intolerance with deficient transport of basic amino acids. An analysis of 10 patients.

Authors:  M Kekomäki; J K Visakorpi; J Perheentupa; L Saxén
Journal:  Acta Paediatr Scand       Date:  1967-11

10.  Renal handling of diamino acids in lysinuric protein intolerance.

Authors:  O Simell; J Perheentupa
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

View more
  6 in total

1.  B and T cell immunity in patients with lysinuric protein intolerance.

Authors:  M Lukkarinen; K Parto; O Ruuskanen; O Vainio; H Käyhty; R M Olander; O Simell
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

2.  Nutrient intake in lysinuric protein intolerance.

Authors:  L M Tanner; K Näntö-Salonen; J Venetoklis; S Kotilainen; H Niinikoski; K Huoponen; O Simell
Journal:  J Inherit Metab Dis       Date:  2007-06-21       Impact factor: 4.982

3.  Immune complex disease consistent with systemic lupus erythematosus in a patient with lysinuric protein intolerance.

Authors:  H Parsons; F Snyder; T Bowen; J Klassen; A Pinto
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

4.  Lysinuric protein intolerance mutation is not expressed in the plasma membrane of erythrocytes.

Authors:  D W Smith; C R Scriver; O Simell
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

5.  Skeletal manifestations of lysinuric protein intolerance. A follow-up study of 29 patients.

Authors:  E Svedström; K Parto; M Marttinen; P Virtama; O Simell
Journal:  Skeletal Radiol       Date:  1993       Impact factor: 2.199

6.  Lysinuric protein intolerance. Basolateral transport defect in renal tubuli.

Authors:  J Rajantie; O Simell; J Perheentupa
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.